| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Clinical and Molecular Hepatology Search > Browse Articles > Search



Clinical significance and predictive factors of early massive recurrence after radiofrequency ablation in patients with a single small hepatocellular carcinoma
Ju-Yeon Cho, Moon Seok Choi, Gil Sun Lee, Won Sohn, Jemma Ahn, Dong-Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Clin Mol Hepatol.2016;22(4):477-486.   Published online December 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0048
                                 Cited By 7
Emergency endoscopic variceal ligation in cirrhotic patients with blood clots in the stomach but no active bleeding or stigmata increases the risk of rebleeding
Su Jin Kim, Cheol Woong Choi, Dae Hwan Kang, Hyung Wook Kim, Su Bum Park, Young Mi Hong, Ki Tae Yoon, Mong Cho, Hyung Seok Nam, SM Bakhtiar UI Islam
Clin Mol Hepatol.2016;22(4):466-476.   Published online December 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0063
                                 Cited By 2
Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization
Sun Hong Yoo, Jeong Won Jang, Jung Hyun Kwon, Seung Min Jung, Bohyun Jang, Jong Young Choi
Clin Mol Hepatol.2016;22(4):458-465.   Published online December 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0054
                                 Cited By 2
Comparison of hepatic MDCT, MRI, and DSA to explant pathology for the detection and treatment planning of hepatocellular carcinoma
Lauren M. Ladd, Temel Tirkes, Mark Tann, David M. Agarwal, Matthew S. Johnson, Bilal Tahir, Kumaresan Sandrasegaran
Clin Mol Hepatol.2016;22(4):450-457.   Published online December 14, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0036
                                 Cited By 3
Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study)
Hye Won Lee, Jun Yong Park, Beom Kyung Kim, Moon Young Kim, Jung Il Lee, Young Suk Kim, Ki Tae Yoon, Kwang-Hyub Han, Sang Hoon Ahn
Clin Mol Hepatol.2016;22(4):443-449.   Published online November 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0037
                                 Cited By 5
Switch to tenofovir-based therapy or to continue adefovir-based therapy in CHB patients with suboptimal response to adefovir-based combination?
Byung-Cheol Song
Clin Mol Hepatol.2016;22(4):439-442.   Published online December 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0108
                              
Management of direct antiviral agent failures
María Buti, Rafael Esteban
Clin Mol Hepatol.2016;22(4):432-438.   Published online December 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0107
                                 Cited By 15
New perspectives of biomarkers for the management of chronic hepatitis B
Chih-Lin Lin, Jia-Horng Kao
Clin Mol Hepatol.2016;22(4):423-431.   Published online December 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0069
                                 Cited By 21
Acute kidney injury in liver cirrhosis: new definition and application
Florence Wong
Clin Mol Hepatol.2016;22(4):415-422.   Published online December 14, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0056
                                 Cited By 18
What we need to know when performing and interpreting US elastography
So Hyun Park, So Yeon Kim, Chong Hyun Suh, Seung Soo Lee, Kyoung Won Kim, So Jung Lee, Moon-Gyu Lee
Clin Mol Hepatol.2016;22(3):406-414.   Published online September 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0106
                                 Cited By 16
Histopathology of a benign bile duct lesion in the liver: Morphologic mimicker or precursor of intrahepatic cholangiocarcinoma
Kyoung-Bun Lee
Clin Mol Hepatol.2016;22(3):400-405.   Published online September 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0105
                                 Cited By 3
A Korean patient with Guillain-Barré syndrome following acute hepatitis E whose cholestasis resolved with steroid therapy
Sung Bok Ji, Sang Soo Lee, Hee cheul Jung, Hong Jun Kim, Hyun Jin Kim, Tae Hyo Kim, Woon Tae Jung, Ok Jae Lee, Dae Hyun Song
Clin Mol Hepatol.2016;22(3):396-399.   Published online August 30, 2016     
DOI: https://doi.org/10.3350/cmh.2015.0039
                                 Cited By 4
Regression of esophageal varices and splenomegaly in two patients with hepatitis-C-related liver cirrhosis after interferon and ribavirin combination therapy
Soon Jae Lee, Yoo-Kyung Cho, Soo-Young Na, Eun Kwang Choi, Sun Jin Boo, Seung Uk Jeong, Hyung Joo Song, Heung Up Kim, Bong Soo Kim, Byung-Cheol Song
Clin Mol Hepatol.2016;22(3):390-395.   Published online August 30, 2016     
DOI: https://doi.org/10.3350/cmh.2015.0050
                                 Cited By 1
Hepatitis B surface antigen titer is a good indicator of durable viral response after entecavir off-treatment for chronic hepatitis B
Han Ah Lee, Yeon Seok Seo, Seung Woon Park, Sang Jung Park, Tae Hyung Kim, Sang Jun Suh, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun, Soon Ho Um
Clin Mol Hepatol.2016;22(3):382-389.   Published online September 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0047
                                 Cited By 4
Decreased C-reactive protein induces abnormal vascular structure in a rat model of liver dysfunction induced by bile duct ligation
Ji Hye Jun, Jong Ho Choi, Si Hyun Bae, Seh Hoon Oh, Gi Jin Kim
Clin Mol Hepatol.2016;22(3):372-381.   Published online September 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0032
                                 Cited By 2
Immunosuppression status of liver transplant recipients with hepatitis C affects biopsy-proven acute rejection
Jong Man Kim, Kwang-Woong Lee, Gi-Won Song, Bo-Hyun Jung, Hae Won Lee, Nam-Joon Yi, ChoonHyuck David Kwon, Shin Hwang, Kyung-Suk Suh, Jae-Won Joh, Suk-Koo Lee, Sung-Gyu Lee
Clin Mol Hepatol.2016;22(3):366-371.   Published online September 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0022
                              
Glypican-3 level assessed by the enzyme-linked immunosorbent assay is inferior to alpha-fetoprotein level for hepatocellular carcinoma diagnosis
Yejoo Jeon, Eun Sun Jang, Yun Suk Choi, Jin-Wook Kim, Sook-Hyang Jeong
Clin Mol Hepatol.2016;22(3):359-365.   Published online September 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0033
                                 Cited By 3
Comparison of the clinical outcomes between antiviral-naïve patients treated with entecavir and lamivudine-resistant patients receiving adefovir add-on lamivudine combination treatment
Hong Joo Kim, Soo Kyung Park, Hyo Joon Yang, Yoon Suk Jung, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim, Kyu Yong Choi
Clin Mol Hepatol.2016;22(3):350-358.   Published online September 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0019
                              
Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B
Jaemin Lee, Sun Hong Yoo, Won Sohn, Hyung Woo Kim, Yong Sun Choi, Jung Ho Won, Jin Young Heo, Sang Jong Park, Young Min Park
Clin Mol Hepatol.2016;22(3):339-349.   Published online September 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0021
                                 Cited By 3
Does obesity increase the risk of hepatocellular carcinoma in chronic hepatitis B patients?
Byoung Kuk Jang
Clin Mol Hepatol.2016;22(3):336-338.   Published online September 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0104
                              
Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment
Hyunwoo Oh, Dae Won Jun, Waqar K Saeed, Mindie H Nguyen
Clin Mol Hepatol.2016;22(3):327-335.   Published online September 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0049
                                 Cited By 21
The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy
Ioannis Varbobitis, George V. Papatheodoridis
Clin Mol Hepatol.2016;22(3):319-326.   Published online September 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0045
                                 Cited By 24
Liver transplantation for advanced hepatocellular carcinoma
Hae Won Lee, Kyung-Suk Suh
Clin Mol Hepatol.2016;22(3):309-318.   Published online September 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0042
                                 Cited By 15
Liver imaging reporting and data system (LI-RADS) version 2014: understanding and application of the diagnostic algorithm
Chansik An, Gulbahor Rakhmonova, Jin-Young Choi, Myeong-Jin Kim
Clin Mol Hepatol.2016;22(2):296-307.   Published online June 15, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0028
                                 Cited By 20
Undifferentiated embryonal sarcoma of the liver in an adult patient
Kyu Ho Lee, Mussin Nadiar Maratovich, Kyoung-Bun Lee
Clin Mol Hepatol.2016;22(2):292-295.   Published online June 25, 2016     
DOI: https://doi.org/10.3350/cmh.2015.0102
                                 Cited By 5
Tenofovir-associated nephrotoxicity in patients with chronic hepatitis B: two cases
Hyeki Cho, Yuri Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Kook-Hwan Oh, Kyoungbun Lee, Syifa Mustika, Jung-Hwan Yoon, Yoon Jun Kim
Clin Mol Hepatol.2016;22(2):286-291.   Published online June 25, 2016     
DOI: https://doi.org/10.3350/cmh.2015.0066
                                 Cited By 3
Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis
Seung Woon Park, Soon Ho Um, Han Ah Lee, Sang Hyun Kim, Yura Sim, Sun Young Yim, Yeon Seok Seo, Ho Sang Ryu
Clin Mol Hepatol.2016;22(2):281-285.   Published online June 1, 2016     
DOI: https://doi.org/10.3350/cmh.2015.0040
                                 Cited By 5
A case of portal hypertension by presumed as plexiform neurofibroma at the hepatic hilum
Kyung Han Lee, Sun Hong Yoo, Gi Tark Noh, Won Suk Heo, Byung Seong Ko, Jung Ah Chio, Hyo Jin Cho, Jin Young Choi, Hee Jun Kim, Won Sohn, Sang Jong Park, Young Min Park
Clin Mol Hepatol.2016;22(2):276-280.   Published online May 20, 2016     
DOI: https://doi.org/10.3350/cmh.2015.0021
                                 Cited By 4
Drug-induced liver injury caused by iodine-131
Chei Won Kim, Ji Sun Park, Se Hwan Oh, Jae-Hyung Park, Hyun-Ik Shim, Jae Woong Yoon, Jin Seok Park, Seong Bin Hong, Jun Mi Kim, Trong Binh Le, Jin Woo Lee
Clin Mol Hepatol.2016;22(2):272-275.   Published online May 20, 2016     
DOI: https://doi.org/10.3350/cmh.2015.0037
                                 Cited By 2
Bone marrow metastasis presenting as bicytopenia originating from hepatocellular carcinoma
Young Mi Hong, Ki Tae Yoon, Mong Cho, Dae Hwan Kang, Hyung Wook Kim, Cheol Woong Choi, Su Bum Park, Jeong Heo, Hyun Young Woo, Won Lim, SM Bakhtiar UI Islam
Clin Mol Hepatol.2016;22(2):267-271.   Published online May 16, 2016     
DOI: https://doi.org/10.3350/cmh.2015.0017
                                 Cited By 1
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next
E-Submission
Email Alert
Author's Index
EndNote Style file download
The Korean Association for the Study of the Liver
The Liver Week 2019
SCImago Journal & Country Rank
PubMed Central
PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
DOAJ
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
ORCID
MeSH on Demand
COPE
Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Association for the Study of the Liver. All rights reserved.         
COUNTER
TODAY : 219
TOTAL : 151271